2019 ¼¿ï¾Æ»êº´¿ø °³¿ø 30Áֳ⠱â³ä Á¾¾çÇÐ ¿¬¼ö°Á : 2019-03-09±³À°ÀÏÀÚ : 2019-03-09
±³À°Àå¼Ò : ¼¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2019 ¼¿ï¾Æ»êº´¿ø °³¿ø 30Áֳ⠱â³ä Á¾¾çÇÐ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ¼¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ¹æÁøÁÖ
¿¬¶ôó : 02-3010-5924
À̸ÞÀÏ :
mbronco@amc.seoul.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í 1. Àü¹®ÀÇ »çÀüÁ¢¼ö 40000¿ø/ ÇöÀåÁ¢¼ö 50000¿ø 2. ÀüÀÓÀÇ,Àü¹®ÀÇ,¾à»ç,°£È£»ç,¿¬±¸¿ø,±âŸ »çÀüÁ¢¼ö 30000¿ø/ ÇöÀåÁ¢¼ö 40000¿ø 3. Á¦¾à»ç »çÀüÁ¢¼ö 60000¿ø/ ÇöÀåÁ¢¼ö 90000¿ø ÀºÇà¸í/°èÁ¹øÈ£/¿¹±ÝÁÖ KEBÇϳªÀºÇà / 253-890062-22605 / ÀÌ´ëÈ£(AMCÁ¾¾ç³»°ú)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 09:30~09:55 Current standard of care and future directions ·ù¹ÎÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 09:55~10:20 Navigating the path through negative data in immune-desert ±è¼±¿µ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 10:20~10:40 Treatment of advanced pancreatic cancer: today and tomorrow ÀåÈï¹®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 10:40~11:00 Bile duct cancer in the precision medicine era ±è±ÔÇ¥(¿ï»êÀÇ´ë)
ÈÞ½Ä 03-09 11:00~11:30 Break ()
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 11:30~12:20 Footsteps of Advancements / Unprecedented challenge ahead ÀÌÁ¤½Å / À±½Å±³(¿ï»êÀÇ´ë)
½Ä»ç 03-09 12:20~13:40 Lunch ()
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 13:40~14:10 Advances in the management of lung cancer: Immunotherapy and Beyond ÀÌ°æ¿ø(°æ»óÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 14:10~14:40 Optimal management of breast cancer: focusing on young breast cancer ±èÁ¤Àº(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 14:40~15:05 Today was once tomorrow. Tomorrow will be today soon. ÀÌ´ëÈ£(¿ï»êÀÇ´ë)
ÈÞ½Ä 03-09 15:05~15:25 Break ()
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 15:25~15:45 Recent Hits and Misses beyond Extreme in metastatic HNC ±è¼º¹è(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 15:45~16:05 Novel therapeutic options for esophageal cancer patients : escape from the darkness? ¹Ú¼÷·Ã(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 16:05~16:30 Genitourinary cancer care evolving with novel agents ÀÌÀç·Ã(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-09 µ¿°ü 6Ãþ ´ë°´ç 16:30~16:50 Are CARs (chimeric antigen receptor T-cells) on the highway for the cure of diffuse large B-cell lymphoma? À±´öÇö(¿ï»êÀÇ´ë)